Silencing RBM17 induced the pro-apoptotic exon 6 inclusion splicing switch in the FAS gene [351]; as well as cell cycle arrest and apoptosis in glioblastoma cells in vitro and decreased tumor growth in a glioblastoma xenograft model in vivo [353], which makes it an interesting target for treatment. The gene discussed is FAS; the disease is glioblastoma.